Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

The sensor accurately measures thallium ions in solutions with high selectivity.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Surgery may be needed for resistant thyrotoxicosis.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Some skin conditions in pets can signal cancer or may develop into cancer, and monitoring or treating these can help detect or manage the disease.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Certain microRNAs found in normal cells can effectively suppress various cancers.

A new compound shows promise as a topical treatment for hair loss.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Pantethine may boost the immune system's ability to fight sarcoma.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Rathke’s cleft cysts can rarely cause Cushing disease, and surgery can improve symptoms.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Some drugs used to treat inflammation may cause hair loss.